Results 21 to 30 of about 63,395 (228)

Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study [PDF]

open access: yes, 1999
Objective: In a prospective multicenter trial, it was our intention to elucidate clinical prognostic factors of seminomas with special reference to the importance of human chorionic gonadotropin (HCG) elevations in histologically pure seminomas. Methods:
Bussar-Maatz, R.   +7 more
core   +1 more source

Clinical evaluation of endolymphatic radiotherapy in malignant lymphoma [PDF]

open access: yes, 1974
By endolymphatic injection of radioisotope 131I.Lipiodol, so.called endolymphatic radiotherapy, we treated 10 cases with malignant lymphoma and found a marked tumor reduction to normal size in all the 10 cases we tried.
Irino, Shozo   +3 more
core   +1 more source

Primary retroperitoneal neuroendocrine tumor with nonspecific presentation: A case report

open access: yesRadiology Case Reports, 2020
Primary retroperitoneal tumors are a rare entity of human neoplasms, with primary retroperitoneal neuroendocrine tumors being even more rare. They are usually metastatic and rarely seen as a primary tumor.
Tareq Hamed Al Taei, MB, BCh, BAO   +2 more
doaj   +1 more source

Clinical features and oncologic outcomes of primary retroperitoneal ganglioneuroma: a retrospective cohort study of 51 patients from a high-volume sarcoma center

open access: yesFrontiers in Surgery
BackgroundRetroperitoneal ganglioneuroma (RGN) is a rare, benign tumor derived from neural crest cells of the sympathetic nervous system. Due to its rarity and complex management, clinical understanding remains limited.
Wenjie Li   +6 more
doaj   +1 more source

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study [PDF]

open access: yes, 2018
Purpose In this multicenter study, we evaluated the cumulative burden of morbidity (CBM) among > 1,200 testicular cancer survivors and applied factor analysis to determine the co-occurrence of adverse health outcomes (AHOs).
AnnaLynn M. Williams   +20 more
core   +1 more source

MASSIVE HAEMORRHAGE DUE TO SPONTANEOUS RUPTURE OF A GIANT RENAL ANGIOMYOLIPOMA – REPORT OF A RARE CASE AND REVIEW OF THE LITERATURE [PDF]

open access: yesTrakia Journal of Sciences, 2019
Massive hemorrhage due to spontaneous rupture of a renal angiomyolipoma is a rare, but the most severe complication of this unusual tumor. The aim of this publication is to present a rare case of massive retroperitoneal hemorrhage and hemoperitoneum due
Iv. Novakov
doaj   +1 more source

Oncologic outcomes following surgical management of clinical stage II sex cord stromal tumors [PDF]

open access: yes, 2019
Objective To investigate the clinical history of patients with clinical stage II sex cord stromal tumors who underwent RPLND at our institution. Methods Our prospectively maintained testicular cancer database was queried to identify patients who ...
Calaway, Adam C.   +3 more
core   +1 more source

Surgical resection for primary retroperitoneal liposarcoma: Analysis of 153 patients treated and followed at a single institution

open access: yesCancer Treatment and Research Communications
Background: This study aimed to identify key prognostic factors influencing disease-free survival (DFS) and overall survival (OS) in patients with primary retroperitoneal liposarcoma (PRPLS), and to evaluate the impact of surgical approach (en bloc vs ...
Haicheng Gao   +5 more
doaj   +1 more source

Giant retroperitoneal dedifferentiated liposarcoma mimicking ovarian cancer: A case report

open access: yesGynecologic Oncology Reports, 2022
Retroperitoneal liposarcoma is a rare tumor, and its dedifferentiated subtype and a larger diameter are associated with a poor prognosis. However, there are few reports of retroperitoneal liposarcomas, both with a dedifferentiated subtype and a diameter ...
Akihiro Tani   +8 more
doaj   +1 more source

Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study

open access: yesFrontiers in Oncology
ObjectiveTo evaluate the efficacy and safety of anlotinib combined with envafolimab in the treatment of unresectable or metastatic liposarcoma.MethodsThis single-center, retrospective study enrolled 15 patients with unresectable or metastatic liposarcoma,
Hongliang Liu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy